Euroapi S.A. (EPA:EAPI)

Market Cap	297.83M
Revenue (ttm)	882.80M
Net Income (ttm)	-124.30M
Shares Out	95.21M
EPS (ttm)	-1.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,862
Average Volume	92,402
Open	3.114
Previous Close	3.096
Day's Range	3.060 - 3.128
52-Week Range	2.260 - 4.460
Beta	0.70
RSI	46.78
Earnings Date	Mar 3, 2026

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances....

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,187
• Stock Exchange: Euronext Paris
• Ticker Symbol: EAPI

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.